This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
by Zacks Equity Research
FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
OMCLPositive Net Change FMSPositive Net Change ATRCPositive Net Change PAHCPositive Net Change
medical medical-devices
3 Medical Device Companies in Focus for Monetizing Data and Analytics
by Indrajit Bandyopadhyay
Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms into recurring revenue engines.
MDTNegative Net Change IQVNegative Net Change GEHCPositive Net Change
medical medical-devices
BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies
by Zacks Equity Research
Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change NVSTPositive Net Change
medical medical-devices
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
by Zacks Equity Research
WST is riding on surging GLP-1 demand and HVP expansion. Yet, pricing pressure, tariff risks and contract manufacturing headwinds cloud the near-term outlook.
CAHPositive Net Change COOPositive Net Change WSTNegative Net Change PAHCPositive Net Change
medical medical-devices
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery
by Zacks Equity Research
Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.
BSXNegative Net Change ATRCPositive Net Change PAHCPositive Net Change KMTSPositive Net Change
medical medical-devices
Reasons to Retain TransMedics Stock in Your Portfolio for Now
by Zacks Equity Research
TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change TMDXPositive Net Change
medical medical-devices
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety
by Zacks Equity Research
BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.
BSXNegative Net Change BAXPositive Net Change IDXXPositive Net Change STENegative Net Change
medical medical-devices
The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic
by Zacks Equity Research
AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power across medtech stocks.
BSXNegative Net Change ANGOPositive Net Change MDTNegative Net Change
medical-devices
BNP Paribas SA (BNPQY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BNPQYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
by Zacks Equity Research
EW benefits from strong TAVR and TMTT momentum, but macro pressures and FX headwinds cloud the near-term outlook.
BSXNegative Net Change EWPositive Net Change PAHCPositive Net Change NVSTPositive Net Change
medical medical-devices